Eltrombopag Tablet, Film Coated
Product Images NDC 0480-2600

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 0480-2600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of eltrombopag, showing its molecular components including aromatic rings, hydroxyl groups, and nitrogen-containing heterocycles, along with associated amine and hydroxyl side groups.*

FDA Label Image

30s (Image 2)

Label for Eltrombopag Tablets 50 mg by Teva Pharmaceuticals, Inc. The label includes dosage form as film-coated oral tablets, package quantity of 30 tablets, and advises swallowing whole without splitting, chewing, or crushing. It also contains storage instructions, dispensing requirements, safety warnings, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.